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Clinical Applications of Contrast 
Echocardiography
Petros Nihoyannopoulos, MD
One of the most recent revolutions of echocardiography has been the introduction 
of intravenous contrast agents for the optimization of echocardiographic imaging. This 
has proven to be of tremendous value, over and above the parallel improvement of 
equipment manufactured and new transducers capable of transmitting and receiving 
ultrasound at different frequencies. There are now clear recommendations by the 
American Society of Echocardiography jointly with the Europeans that regular use 
of intravenous contrast agents in echocardiography benefits image interpretation at 
rest and perhaps even more, during stress [1,2].
The symposium held during the Euroecho 8 congress in Athens, December 2004 
on “Clinical value and perspectives of Contrast Echocardiography” gives us the op-
portunity to highlight the most important clinical implementations but also research 
opportunities ready to be implemented in clinical echocardiography today.
There are now a number of second generation echo-contrast agents that have been 
in the market for several years all over the world and there are more to come very 
soon in the market, demonstrating the benefit of those agents. In the United States, 
Optison and Definity are routinely used to improve image quality. In Europe, Optison 
and Sonovue are used for the same indications. Several hundreds of thousands of 
patients have received echo-contrast todate and compared to other contrast agents 
used in imaging, echo contrast agents are the safest [3]. During that symposium, 
experts from all-over Europe presented their experience in considering current but 
also some future applications of contrast echocardiography. These new possibilities 
are clearly illustrated in the articles of this supplement from which some important 
remarks can be drawn.
Image quality is crucial to formulate a diagnosis. Even experts can produce poor 
images and need to use contrast to improve quality. This is particularly important 
when other non-experts in echocardiography are looking at the pictures in order to 
make a clinical decision and if image quality is not convincing, then they will turn into 
alternative imaging modalities that may produce a better picture. One good picture 
is worth a thousand words! 
Using contrast echocardiography and thus improving endocardial delineation of 
the left ventricle, allows for a better and more reproducible assessment of left ventricu-
lar ejection fraction in such a way that is comparable to cardiac magnetic resonance 
imaging (CMR) with only a fraction of its cost. This has been elegantly demonstrated 
by Hoffmann et al who used Sonovue in 120 patients from several centers in order to 
determine the agreement of unenhanced and contrast-enhanced echocardiography 
against biplane cine-ventriculography and CMR [4]. They convincingly showed that 
contrast-enhanced echocardiography significantly improves inter-observer variability 
for the assessment of ejection fraction to a level obtained by CMR, while cine-ven-
triculography exhibits a large inter-observer variability [4]. Furthermore, assessing re-
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gional ventricular function is crucial when assessing coronary 
artery disease patients. In this symposium, Dr Roxy Senior 
outlined the benefits of using contrast in such patients, both 
at rest and during stress, as derived from several single- and 
multi-center trials [2,5].
Perhaps the Holly Grail of contrast echocardiography is 
the detection of myocardial perfusion. Although this does not 
constitute a clinical indication for use of contrast at present, 
several laboratories use intravenous contrast agents in echo-
cardiography for the assessment of myocardial opacification, 
over and above the better endocardial definition. In this way, 
one can obtain improved image quality but also indication on 
myocardial perfusion simultaneously. There is now a wealth 
of data derived from several studies demonstrating similar 
information being obtained from myocardial contrast echo-
cardiography (MCE) and single photon emission computed 
tomography (SPECT) imaging [6-10] in terms of myocardial 
perfusion in a qualitative way. It is important however for any 
imaging modality to be able to quantify the information, which 
gives more objective and less operator-dependent informa-
tion. Intravenous injection of microbubbles for MCE allows 
measurements of myocardial blood volumes and myocardial 
blood velocities. Interestingly, the product of myocardial blood 
volume and velocity provides a measure for myocardial blood 
flow [11-13], which can now be quantified and ultimately pro-
vide an alternative to positron emission tomography (PET) 
at a fraction of its cost. Unfortunately, what many centers 
currently use for assessing myocardial perfusion of the heart 
is SPECT, which of course only provides relative assessment 
of myocardial blood volumes between segments, thus lacking 
the measurement of myocardial perfusion. New methods of 
quantitation of myocardial perfusion have been detailed by 
Dr Luciano Agati during this symposium on contrast echo-
cardiography. The qualitative and quantitative assessment 
of myocardial perfusion could thus provide additional and 
important information on patient outcomes. 
Contrast echocardiography is a safe procedure [14]. Echo 
contrast agents have an excellent safety profile compared to all 
the other contrast agents used for X-ray, radioactive materials 
used in nuclear medicine, computed tomography or magnetic 
resonance imaging as they have the least side effects [3]. How-
ever, all contrast agents may induce allergic reactions, which 
physicians have to be prepared for and patients should there-
fore be under medical supervision after contrast injection.
T A K E  H O M E  M E S S A G E S :
• Contrast echocardiography is commercially available and 
it is here to stay. Primary indication is to optimize assess-
ment of left ventricular function at rest and during stress. 
It is alleged that some 20% of patients undergoing stress 
echocardiography have sub-optimal endocardial defini-
tion. All those patients ought to have contrast!
• Numerous research studies have demonstrated that intra-
venous contrast injection may opacify the myocardium, 
thus providing unique information on myocardial perfu-
sion. Although no specific clinical indication for perfusion 
currently exists, this concomitant information may be of 
great additional value during stress.
• Finally, on the safety issue; transvenous administration 
of contrast agents for echocardiography is safe, certainly 
safer than many of the contrast agents used in radiology. 
All contrast agents may produce allergic reactions and 
echo contrast agents may do the same.
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